Today: First Midwest Bank Trust Division Maintains Stake in Cantel Medical Corp. (CMN)

Today: First Midwest Bank Trust Division Maintains Stake in Cantel Medical Corp. (CMN)

First Midwest Bank Trust Division held its position in Cantel Medical Corp. (NYSE:CMN) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,412 shares of the company’s stock at the end of the third quarter. First Midwest Bank Trust Division’s holdings in Cantel Medical Corp. were worth $1,592,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. A.R.T. Advisors LLC increased its stake in shares of Cantel Medical Corp. by 23.1% in the first quarter. A.R.T. Advisors LLC now owns 9,587 shares of the company’s stock valued at $684,000 after buying an additional 1,800 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of Cantel Medical Corp. by 116.8% in the second quarter. BNP Paribas Arbitrage SA now owns 11,228 shares of the company’s stock valued at $772,000 after buying an additional 6,050 shares during the period. Capstone Asset Management Co. increased its stake in shares of Cantel Medical Corp. by 9.7% in the second quarter. Capstone Asset Management Co. now owns 13,475 shares of the company’s stock valued at $926,000 after buying an additional 1,190 shares during the period. LS Investment Advisors LLC increased its stake in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock valued at $104,000 after buying an additional 106 shares during the period. Finally, New York State Teachers Retirement System increased its stake in shares of Cantel Medical Corp. by 12.0% in the second quarter. New York State Teachers Retirement System now owns 42,924 shares of the company’s stock valued at $2,950,000 after buying an additional 4,600 shares during the period. 82.99% of the stock is currently owned by institutional investors and hedge funds.

Shares of Cantel Medical Corp. (NYSE:CMN) opened at 81.87 on Monday. Cantel Medical Corp. has a 12-month low of $55.01 and a 12-month high of $82.80. The firm has a market capitalization of $3.39 billion, a P/E ratio of 56.93 and a beta of 1.41. The stock has a 50 day moving average of $75.04 and a 200-day moving average of $72.33.

Cantel Medical Corp. (NYSE:CMN) last released its quarterly earnings data on Thursday, September 29th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The company earned $179 million during the quarter. During the same period in the prior year, the company earned $0.39 EPS. The business’s quarterly revenue was up 18.3% compared to the same quarter last year. On average, equities research analysts predict that Cantel Medical Corp. will post $1.96 EPS for the current fiscal year.

The company also recently disclosed a semiannual dividend, which will be paid on Tuesday, January 31st. Stockholders of record on Tuesday, January 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Thursday, January 12th. This represents a dividend yield of 0.18%. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06. Cantel Medical Corp.’s dividend payout ratio is currently 8.33%.

Several analysts have commented on the stock. Benchmark Co. set a $83.00 target price on shares of Cantel Medical Corp. and gave the stock a “buy” rating in a report on Saturday, October 1st. Needham & Company LLC began coverage on shares of Cantel Medical Corp. in a report on Wednesday, August 24th. They issued a “hold” rating on the stock.

In related news, Chairman Charles M. Diker sold 14,897 shares of the company’s stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $78.76, for a total value of $1,173,287.72. Following the sale, the chairman now directly owns 3,190,111 shares in the company, valued at $251,253,142.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ann E. Berman sold 1,453 shares of the company’s stock in a transaction that occurred on Friday, September 30th. The shares were sold at an average price of $77.56, for a total value of $112,694.68. Following the completion of the sale, the director now owns 5,424 shares in the company, valued at $420,685.44. The disclosure for this sale can be found here. 15.30% of the stock is owned by insiders.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Related posts

Leave a Comment